On December 17, 2019, ANAB continued Signature Science’s Forensic DNA Laboratory's accreditation in the field of Forensic Testing and discipline of Biology. The accreditation is for a period of two years, ending on January 31, 2022. ANAB was satisfied that Signature Science met or exceeded the requirements for accreditation as... MORE
SigSci-Led Team Awarded $1.57M DARPA Contract to Develop Spore-Phage Amplified Detection for Aubterranean Chemical Threats
Researchers from Signature Science and the Texas A&M University Center for Phage Technology aim to develop a new platform to recognize chemical threats underground. AUSTIN, TEXAS – Nov. 12, 2019 – Signature Science, LLC was awarded a $1.57 million contract to develop the Spore-Phage Amplified Detection (SPADe) method in response... MORE
Researchers from Signature Science, University of North Texas Health Science Center, and The Ohio State University are combining their proteogenomic and investigative genetics expertise to develop a new method (called Proteo-ID) for human forensic analysis based on protein sequence, enabling the forensic analysis of samples that contain little or no... MORE
AUSTIN, TEXAS – April 23, 2019 – Signature Science, LLC has been awarded funding for Phase 2 of their work supporting the Intelligence Advanced Research Projects Activity’s (IARPA) Functional Genomic and Computational Assessment of Threats (Fun GCAT) program. The research team will continue development of their Sequence to Functional Analysis... MORE
AUSTIN, TEXAS — February 12, 2019 — Signature Science, LLC has been awarded a contract from the Department of Defense (DOD) Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) in support of the Multi-Phase Chemical Agent Detector (MPCAD) program. The Other Transaction Authority (OTA) award is... MORE
Dr. Turner will apply his informatics and genomics expertise to the development of leading-edge forensic genomics solutions for national security, defense, and law enforcement challenges, such as cold case investigations. AUSTIN, TEXAS — Feb. 5, 2019 - Signature Science, LLC is pleased to announce that Dr. Stephen Turner has joined... MORE
SigSci Awarded a CDC Contract to Study Simulated Pathogen Transmission in Healthcare Settings Using Metagenomic...
Researchers from Signature Science will evaluate and develop tools which can detect and follow the spread of specific bacteria and microbial communities between people and across surfaces in healthcare settings. AUSTIN, TEXAS — Nov. 27, 2018 — The Centers for Disease Control and Prevention (CDC) has awarded Signature Science, LLC... MORE
SigSci Awarded $2.3M IARPA Contract to Develop Novel Forensic Identification Methods that Sequence Protein Instead...
AUSTIN, TEXAS — August 08, 2018 — The Intelligence Advanced Research Projects Activity (IARPA) awarded Signature Science, LLC, a $2.3M contract for the development of the Proteo-ID method. Proteo-ID aims to accurately identify people via protein sequencing from human skin cell samples. The Proteo-ID methodology will significantly expand human forensic... MORE
Austin, Texas – September 21, 2017 – The Intelligence Advanced Research Projects Activity (IARPA) awarded Signature Science, LLC a $2.9M contract for the development of new computational tools to screen DNA sequences to detect biological threats that may manifest from synthetic microbial manipulation. The challenge is to overcome the speed... MORE